Barriers of thrombolysis therapy in developing countries

Ghandehari, K. (2011) Barriers of thrombolysis therapy in developing countries. Stroke Research and Treatment.

[img] Text

Download (482kB)
[img] Text
Barriers of thrombolysis therapy in developing countries.pdf

Download (482kB)


The developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in developing countries. Until a cheaper thrombolytic agent and the proper infrastructure for utilization of thrombolytic therapy is available, developing countries should focus on primary and secondary stroke prevention strategies. However, governments and health systems of developing countries should efforts exerb for promotion of their infrastructure of stroke care. Copyright © 2011 Kavian Ghandehari.

Item Type: Article
Additional Information: Cited By :30 Export Date: 16 February 2020 Correspondence Address: Ghandehari, K.; Neuroscience Research Center, Mashhad University of Medical Sciences, P.O. Box: 91766-99199, Mashhad, Iran; email:
Uncontrolled Keywords: alteplase fibrinolytic agent brain hemorrhage developing country drug cost drug safety fibrinolytic therapy financial management health care cost health care system health insurance human priority journal race difference review stroke vascular disease
Subjects: WH Hemic and Lymphatic System
QU Biochemistry
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib7 lib7
Date Deposited: 19 Apr 2020 10:06
Last Modified: 19 Apr 2020 10:06

Actions (login required)

View Item View Item